MedTrace Logo

Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population

NCT00799695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 561

Last updated 2008-12-01

No results posted yet for this study

Summary

Diabetic retinopathy is the major cause of blindness in working age Americans, and screening for it is cost-effective. There are a quarter of a million people in Southeast Michigan with diabetes and pre-diabetes.

Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions.

This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations.

Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times.

Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.

Conditions

Interventions

BEHAVIORAL

phone call contact

A sample of subjects who had not completed their annual diabetic screening exams were contacted by phone and offered appointments for eye exams

Sponsors & Collaborators

  • Blue Cross Blue Shield of Michigan Foundation

    collaborator OTHER

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Robert M Levine,, MD · Henry Ford Health System

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-05-31
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00799695 on ClinicalTrials.gov